| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4cc8283dd5112c85aeb567da229d0c3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate |
2016-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9df934145b605ca5d3b6b150a92f25f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f481f7ad9201bfb19e8df49bcd75d5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_317c0c87f70a68148ca61772de148ae2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85a226becc4c8519994cea49a60f2714 |
| publicationDate |
2020-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2718984-C2 |
| titleOfInvention |
Single-stranded nucleic acid molecule inhibiting expression of prorenin gene or prorenin receptor gene, and use thereof |
| abstract |
FIELD: biotechnology. n SUBSTANCE: invention relates to the field of biotechnology. Described is a group of inventions comprising a single-stranded nucleic molecule that inhibits the expression of the prorenin gene or the prorenin receptor gene, a prorenin gene expression inhibitor or prorenin receptor gene, a therapeutic agent for eye diseases containing said nucleic acid molecule, a method of inhibiting prorenin gene expression or prorenin receptor gene involving using said nucleic acid molecule, use of said nucleic acid molecule for producing a prorenin gene expression inhibitor or prorenin receptor gene. n EFFECT: invention extends the range of agents for inhibiting prorenin expression gene or prorenin receptor gene. n 24 cl, 14 dwg, 3 tbl, 8 ex |
| priorityDate |
2015-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |